| Financial Year |
March 31 2023 |
| Monetary Funds |
4,503,111,737.88 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
71,708,308.63 |
| Advances to Suppliers |
525,402,423.61 |
| Other Receivables |
1,856,201.97 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
964,084,373.73 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
37,778,295.12 |
| Total Current Assets |
7,207,227,888.97 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,370,283,707.08 |
| Investment Properties |
5,060,673.21 |
| Fixed Assetes |
8,980,430,590.30 |
| Under-construction Projects |
547,995,710.19 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
740,310,108.83 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
28,788,411.68 |
| Deferred Income Tax Assets |
11,283,691.40 |
| Other Non-Current Assets |
65,253,874.46 |
| Sub-Total of Non-Current Assets |
11,754,553,523.81 |
| Total Assets |
18,961,781,412.78 |
| Short-Term Loans |
665,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
1,624,551,718.11 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
70,444,517.19 |
| Taxes Payable |
91,989,616.67 |
| Interest Payable |
-- |
| Dividend Payable |
2,060,475.00 |
| Other payables |
247,103,771.03 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
23,000,000.00 |
| Other Current Liabilities |
50,701,252.53 |
| Sub-Total of Current Liabilities |
3,192,758,870.08 |
| Long-term Loans |
2,249,000,000.00 |
| Bonds Payable |
2,695,655,027.24 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
20,124,301.78 |
| Other Non-Current Liabilities |
165,000,000.00 |
| Sub-Total of Non-Current Liabilities |
5,165,894,407.38 |
| Total Liabilities |
8,358,653,277.46 |
| Paid-In Capital(Or Share Stock) |
1,707,360,761.00 |
| Capital Surplus |
1,910,446,435.54 |
| Surplus Reserve |
929,298,787.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
5,685,122,657.86 |
| Minority Stockholder's Interest |
12,863,805.40 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,590,264,329.92 |
| Owner's Equity（Stockholder's Equity） |
10,603,128,135.32 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,961,781,412.78 |
